Nicola Alexander Hanania (Nicola A Hanania)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 17

Top Topics

Peritoneal Dialysis

Chronic Obstructive Pulmonary Disease

Psychometric Properties

Allergic Rhinitis

Top Venues

Respirology (Carlton, Vic.)

Influenza and other respiratory viruses

International journal of chronic obstructive pulmonary disease

Postgraduate medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Muhammad Adrish, Nicola Alexander Hanania
Asthma and cardiovascular disease: A bidirectional association? Respirology (Carlton, Vic.) 28 (3) (2023)
Christopher Wallick, Tu My To, Stephan Korom, Henry Masters, Ning Wu, Dalia Moawad, Nicola Alexander Hanania
Impact of antiviral therapy on short- and long-term outcomes of patients with chronic obstructive pulmonary disease after influenza infection. Influenza and other respiratory viruses 17 (12) (2023)
Nicola Alexander Hanania, Scott H Bunner, Lindsay G S Bengtson, Afisi S Ismaila, Michael Bogart
COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA. International journal of chronic obstructive pulmonary disease 18 (2023)
Muhammad Adrish, Nicola Alexander Hanania
Asthma and cardiovascular disease: A bidirectional association? Respirology (Carlton, Vic.) 28 (3) (2023)
Muhammad Adrish, Nicola Alexander Hanania
Asthma and cardiovascular disease: A bidirectional association? Respirology (Carlton, Vic.) 28 (3) (2023)
Christopher Wallick, Tu My To, Stephan Korom, Henry Masters, Ning Wu, Dalia Moawad, Nicola Alexander Hanania
Impact of antiviral therapy on short- and long-term outcomes of patients with chronic obstructive pulmonary disease after influenza infection. Influenza and other respiratory viruses 17 (12) (2023)
Nicola Alexander Hanania, Scott H Bunner, Lindsay G S Bengtson, Afisi S Ismaila, Michael Bogart
COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA. International journal of chronic obstructive pulmonary disease 18 (2023)
Muhammad Adrish, Nicola Alexander Hanania
Asthma and cardiovascular disease: A bidirectional association? Respirology (Carlton, Vic.) (2023)
Christopher Wallick, Tu My To, Stephan Korom, Henry Masters, Ning Wu, Dalia Moawad, Nicola Alexander Hanania
Impact of antiviral therapy on short- and long-term outcomes of patients with chronic obstructive pulmonary disease after influenza infection. Influenza and other respiratory viruses 17 (12) (2023)
Christopher Wallick, Tu My To, Stephan Korom, Henry Masters, Ning Wu, Dalia Moawad, Nicola Alexander Hanania
Impact of antiviral therapy on short- and long-term outcomes of patients with chronic obstructive pulmonary disease after influenza infection. Influenza and other respiratory viruses 17 (12) (2023)
Muhammad Adrish, Nicola Alexander Hanania
Asthma and cardiovascular disease: A bidirectional association? Respirology (Carlton, Vic.) 28 (3) (2023)
Nicola Alexander Hanania, Scott H Bunner, Lindsay G S Bengtson, Afisi S Ismaila, Michael Bogart
COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA. International journal of chronic obstructive pulmonary disease 18 (2023)
Muhammad Adrish, Nicola Alexander Hanania
Choosing and switching biological agents in severe asthma. Respirology (Carlton, Vic.) 27 (11) (2022)
Alpesh N Amin, Sharon D Cornelison, J Andrew Woods, Nicola Alexander Hanania
Managing hospitalized patients with a COPD exacerbation: the role of hospitalists and the multidisciplinary team. Postgraduate medicine 134 (2) (2021)
Nicola Alexander Hanania, Scott Caveney, Tedi Soule, Lee Tombs, Sally Lettis, Courtney Crim, Byron M Thomashow, Hitesh Patel, Isabelle H Boucot
Effect of Age on Efficacy and Safety of Fluticasone Furoate/Vilanterol (FF/VI), Umeclidinium (UMEC), and UMEC + FF/VI in Patients with Chronic Obstructive Pulmonary Disease: Analyses of Five Randomized Clinical Trials. International journal of chronic obstructive pulmonary disease 16 (2021)
Abebaw Mengistu Yohannes, Michelle N Eakin, Janet T Holbrook, Elizabeth A Sugar, Robert Henderson, Anna M Baker, Anne S Casper, David A Kaminsky, Alexis L Rea, Anne M Mathews, Loretta G Que, Joe W Ramsdell, Lynn B Gerald, Robert A Wise, Nicola Alexander Hanania
Association of mild cognitive impairment and characteristic of COPD and overall health status in a cohort study. Expert review of respiratory medicine 15 (1) (2020)
Abebaw Mengistu Yohannes, Sheila Dryden, Nicola Alexander Hanania
The responsiveness of the Manchester Chronic Obstructive Pulmonary Disease Fatigue Scale to pulmonary rehabilitation. Therapeutic advances in chronic disease 10 (2019)